Molecular systems biology of ErbB1 signaling: Bridging the gap through multiscale modeling and high-performance computing

Molecular BioSystems

Volumn 4, Issue 12, 2008, Pages 1151-1159

  Shih, Andrew J ^a   Purvis, Jeremy ^b   Radhakrishnan, Ravi ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; COMPUTER ANALYSIS; COMPUTER SIMULATION; ENZYME SPECIFICITY; HUMAN; METABOLISM; MOLECULAR BIOLOGY; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

COMPUTER SIMULATION; COMPUTING METHODOLOGIES; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR BIOLOGY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; SYSTEMS BIOLOGY;

EID: 56349159166     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/b803806f     Document Type: Article

References (48)

1. Y. Yarden M. X. Sliwkowski Untangling the ErbB Signaling Network Nat. Rev. Mol. Cell Biol. 2001 2 127 137
2. A. Citri Y. Yarden EGF-ERBB signaling: towards the systems level Nat. Rev. Mol. Cell Biol. 2006 7 505 516
3. B. Schoeberl C. E. Jonsson E. D. Gilles G. Muller Computational modeling of the dynamics of MAPKinase cascade activated by surface and internalized receptors Nat. Biotechnol. 2002 20 370 375
4. M. Hatakeyama S. Kimura N. Yumoto M. Ichikawa T. Kawasaki T. Naka A. Konagaya A computational model on the modulation of MAPK and Akt pathways in Heregulin-induced ERB signaling Biochem. J. 2003 373 451 463
5. B. N. Kholodenko O. V. Demin G. Moehren J. B. Hoek Quantification of short term signaling by the epidermal growth factor receptor J. Biol. Chem. 1999 274 30169 30181
6. B. N. Kholodenko Cell-signalling dynamics in time and space Nat. Rev. Mol. Cell Biol. 2006 7 165 176
7. J. Schlessinger Cell signaling by receptor tyrosine kinases Cell 2000 103 211 225
8. M. T. Kloth K. K. Laughlin J. S. Biscardi J. L. Boerner S. J. Parsons C. M. Silva STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor J. Biol. Chem. 2003 278 1671 1679
9. A. V. Vieira C. Lamaze S. L. Schmid Control of EGF Receptor signaling by clathrim-mediated endocytosis Science 1996 274 2066 2089
10. J. Mendelsohn J. Baselga The EGF receptor family as targets for cancer therapy Oncogene 2000 19 6550 6565
11. B. Linggi G. Carpenter ErbB receptors: new insights on mechanisms and biology Trends Cell Biol. 2006 16 649 656
12. Y. Liu J. Purvis A. Shih J. Weinstein N. Agrawal R. Radhakrishnan A Multiscale Computational Approach to Dissect Early Events in the Erb Family Receptor, Mediated Activation Differential Signaling, and Relevance to Oncogenic Transformations Ann. Biomed. Eng. 2007 35 1012 1025
13. A. Shih, S.-H. Choi, M. A. Lemmon and R. Radhakrishnan, Network of Stabilizing Hydrogen Bonds is Integral to the Dimer-Mediated Allosteric Activation Mechanism in the ErbB1 and ErbB4 Kinase, 2008, submitted
14. J. Purvis, Y. Liu, V. Ilango and R. Radhakrishnan, Efficacy of tyrosine kinase inhibitors in the mutants of the epidermal growth factor receptor: A multiscale molecular/systems model for phosphorylation and inhibition, in Proc. Foundations in Systems Biology II, IRB Verlag, Stuttgart, 2007, pp. 289-294
15. J. Purvis V. Ilango R. Radhakrishnan Role of Network Branching in Eliciting Differential Short-Term Signaling Responses in the Hyper-Sensitive Epidermal Growth Factor Receptor Mutants Implicated in Lung Cancer Biotechnol. Prog. 2008 24 540 553
16. K. S. Brown C. C. Hill G. A. Calero C. R. Myers K. H. Lee J. P. Sethna R. A. Cerione The statistical mechanics of complex signaling networks: nerve growth factor signaling Phys. Biol. 2004 1 184 195
17. J. Weinstein R. Radhakrishnan A coarse-grained methodology for simulating interfacial dynamics in complex fluids: application to protein mediated membrane processes Mol. Phys. 2006 104 3653 3666
18. N. Agrawal, J. Weinstein and R. Radhakrishnan, Landscape of membrane-phase behavior under the influence of curvature-inducing proteins, 2008, submitted
19. R. Sordella D. W. Bell D. A. Haber J. Settleman Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways Science 2004 305 1163 1167
20. K. D. Carey A. J. Garton M. S. Romero J. Kahler S. Thomson S. Ross F. Park J. D. Haley N. Gibson M. X. Sliwkowski Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib Cancer Res. 2006 66 8163 8171
21. X. Zhang J. Gureasko K. Shen P. A. Cole J. Kuriyan An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor Cell 2006 125 1137 1149
22. C. Qiu M. K. Tarrant S. H. Choi A. Sathyamurthy R. Bose S. Banjade A. Pal W. G. Bornmann M. A. Lemmon P. A. Cole D. J. Leahy Mechanism of activation and inhibition of the HER4/ErbB4 kinase Structure 2008 16 460 467
23. W. X. Schulze L. Deng M. Mann Phosphotyrosine interactome of the ErbB-receptor kinase family Mol. Syst. Biol. 2005 1
24. R. Mulloy A. Ferrand Y. Kim R. Sordella D. W. Bell D. A. Haber K. S. Anderson J. Settleman Epidermal growth factor receptor mutants from human lung cancers exhibit enhanced catalytic activity and increased sensitivity to gefitinib Cancer Res. 2007 67 2325 2330
25. S. Tracy T. Mukohara M. Hansen M. Meyerson B. E. Johnson P. A. Janne Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255 Cancer Res. 2004 64 7241 7244
26. T. J. Lynch D. W. Bell R. Sordella S. Gurubhagavatula R. A. Okimoto B. W. Brannigan P. L. Harris S. M. Haserlat J. G. Supko F. G. Haluska D. N. Louis D. C. Christiani J. Settleman D. A. Haber Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N. Engl. J. Med. 2004 350 2129 2139
27. S. V. Sharma P. Gajowniczek I. P. Way D. Y. Lee J. Jiang Y. Yuza M. Classon D. A. Haber J. Settleman A common signaling cascade may underlie "addiction" to the Src, BCR-ABL, and EGF receptor oncogenes Cancer Cell 2006 10 425 435
28. I. B. Weinstein Cancer. Addiction to oncogenes - the Achilles heal of cancer Science 2002 297 63 64
29. N. Duesbery G. Vande Woude BRAF and MEK mutations make a late entrance Sci. STKE 2006 2006 pe15
30. M. Bentires-Alj S. G. Gil R. Chan Z. C. Wang Y. Wang N. Imanaka L. N. Harris A. Richardson B. G. Neel H. Gu A role for the scaffolding adapter GAB2 in breast cancer Nat. Med. 2006 12 114 121
31. C. Mascaux N. Iannino B. Martin M. Paesmans T. Berghmans M. Dusart A. Haller P. Lothaire A. P. Meert S. Noel J. J. Lafitte J. P. Sculier The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis Br. J. Cancer 2005 92 131 139
32. Y. Samuels Z. Wang A. Bardelli N. Silliman J. Ptak S. Szabo H. Yan A. Gazdar S. M. Powell G. J. Riggins J. K. V. Willson S. Markowitz K. W. Kinzler B. Vogelstein V. E. Velculescu High Frequency of Mutations of the PIK3CA Gene in Human Cancers Science 2004 304 554
33. T. Sjoblom S. Jones L. D. Wood D. W. Parsons J. Lin T. D. Barber D. Mandelker R. J. Leary J. Ptak N. Silliman S. Szabo P. Buckhaults C. Farrell P. Meeh S. D. Markowitz J. Willis D. Dawson J. K. V. Willson A. F. Gazdar J. Hartigan L. Wu C. Liu G. Parmigiani B. H. Park K. E. Bachman N. Papadopoulos B. Vogelstein K. W. Kinzler V. E. Velculescu The Consensus Coding Sequences of Human Breast and Colorectal Cancers Science 2006 314 268 274
34. H. Venter R. A. Shilling S. Velamakanni L. Balakrishnan H. W. v. Veen An ABC transporter with a secondary-active multidrug translocator domain Nature 2003 426 866 870
35. S. Blencke A. Ullrich H. Daub Mutation of threonine 766 in the epidermal growth factor receptor reveals a hotspot for resistance formation against selective tyrosine kinase inhibitors J. Biol. Chem. 2003 278 15435 15440
36. B. Liu B. Bernard J. H. Wu Impact of EGFR point mutations on the sensitivity to gefitinib: Insights from comparative structural analyses and molecular dynamics simulations Proteins: Struct., Funct., Bioinf. 2006 65 331 346
37. J. A. Engelman K. Zejnullahu T. Mitsudomi Y. Song C. Hyland J. O. Park N. Lindeman C.-M. Gale X. Zhao J. Christensen T. Kosaka A. J. Holmes A. M. Rogers F. Cappuzzo T. Mok C. Lee B. E. Johnson L. C. Cantley P. A. Janne MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling Science 2007 316 1039 1043
38. N. V. Sergina M. Rausch D. H. Wang J. Blair B. Hann K. M. Shokat M. M. Moasser Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3 Nature 2007 445 437 441
39. S. L. Petersen L. Wang A. Yalcin-Chin L. Li M. Peyton J. Minna P. Harran X. Wang Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis Cancer Cell 2007 12 445 456
40. A. Suenaga, M. Hatakeyama, A. B. Kiyatkin, R. Radhakrishnan, M. Taiji and B. N. Kholodenko, Tyr-317 Phosphorylation Reduces Shc Binding Affinity for Phosphotyrosyl Residues of Epidermal Growth Factor Receptor, 2008, submitted
41. M. R. Birtwistle M. Hatakeyama N. Yumoto B. A. Ogunnaike J. B. Hoek B. N. Kholodenko Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses Mol. Syst. Biol. 2007 3 144
42. H. Waterman Y. Yarden Molecular mechanisms underlying endocytosis and sorting of Erb receptor tyrosine kinases FEBS Lett. 2001 490 142 152
43. J. W. Lee Y. H. Soung S. H. Seo S. Y. Kim C. H. Park Y. P. Wang K. Park S. W. Nam W. S. Park S. H. Kim J. Y. Lee N. J. Yoo S. H. Lee Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas Clin. Cancer Res. 2006 12 57 61
44. A. Sorkin M. Von Zastrow Signal transduction and endocytosis: close encounters of many kinds Nat. Rev. Mol. Cell Biol. 2002 3 600 614
45. K. G. Bache T. Slagsvold H. Stenmark Defective downregulation of receptor tyrosine kinases in cancer EMBO J. 2004 23 2707 2712
46. S. Polo S. Pece P. P. Di Fiore Endocytosis and cancer Curr. Opin. Cell Biol. 2004 16 156 161
47. S. Floyd P. D. Camilli Endocytosis proteins and cancer: a potential link Trends Cell Biol. 1998 8 299 301
48. B. S. Hendriks G. J. Griffiths R. Benson D. Kenyon M. Lazzara J. Swinton S. Beck M. Hickinson J. M. Beusmans D. Lauffenburger D. De Graaf Decreased internalisation of ErbB1 mutants in lung cancer is linked with a mechanism conferring sensitivity to gefitinib IEE Proc. Syst. Biol. 2006 153 457 466